BioNTech

BioNTech多重博弈：Moderna觊觎工厂、168亿现金护盘、肿瘤数据成最后定音

Brett Shapiro -

BioNTech的”双重试炼”：从新冠捍卫者到肿瘤帝国，分步验证策略下的股价窄幅博弈

Brett Shapiro -

BioNTech悬崖边的豪赌：关厂减支、两创始交棒、肿瘤管线七轮数据定命运

kashif hafeez -

BioNTech Nears a Crossroads: Factory Closures, Founder Exits, and a Cancer-Pipeline Bet Are All Converging

kashif hafeez -

BioNTech转型迷雾：降目标、迎换帅、押注15项肿瘤临床，市场等待8月财报定方向

BioNTech’s Pivotal Week: A Legal Win, Factory Talks with Moderna, and a Looming Leadership Void

angelina -

BioNTech 2026大重构：关厂减支、创始人退场与15项三期临床的终极考验

BioNTech双线告捷：专利战裁定胜利，ADC肿瘤药步入FDA审批通道

BioNTech Prepares for a Pivotal Year: Seven Late-Stage Trials, Cost Cuts, and a Change at the Helm

BioNTech”自断经脉”求生：五厂甩卖与创始人”出走”背后的背水一战

angelina -

BioNTech’s Patent Win and Lancet Validation Contrast With Analyst Downgrades

angelina -

BioNTech Charts a New Course: Factory Fire Sale and Founder Exit Amid a Cancer Bet

kashif hafeez -

BioNTech”后新冠时代”三线突围：卖厂缩编、创始人交棒、十亿美元回购护盘

angelina -

BioNTech Races Toward an Oncology Pivot as Factory Sales and a Prostate Cancer Trial Drive Sentiment

kashif hafeez -

BioNTech战略转向：关厂变卖厂，五处基地迎来买家谈判

kashif hafeez -
123...12Page 2 of 12